open access

Vol 13, No 2 (2010)
Brief communication
Published online: 2011-05-20
Submitted: 2012-01-23
Get Citation

The usefulness of sentinel lymph node detection in vulvar cancer — a short communication

Sambor Sawicki, Grzegorz Romanowicz, Dariusz Wydra, Piotr Lass
Nucl. Med. Rev 2010;13(2):81-83.

open access

Vol 13, No 2 (2010)
Short communications
Published online: 2011-05-20
Submitted: 2012-01-23

Abstract

BACKGROUND: The sentinel lymph node (SLN) biopsy is a solution for decreasing the extent of surgery with a significant reduction of the incidence of complications without influencing treatment results.
MATERIAL AND METHODS: We performed the sentinel lymph node procedure in 24 women with vulvar cancer. In 14 cases, only the blue dye technique was applied, and in 10 cases 99mTc-labelled nanocolloid with blue dye was administered simultaneously. The extent of the surgery included radical vulvectomy in 23 patients and a wide local excision in 1 patient. In 15 patients unilateral inguinofemoral lymphadenectomy was performed and in 9 cases bilateral lymphadenectomy. The total number of operated groins was 39.
RESULTS: SLNs were detected in 34/39 of operated groins (87.2%). In 4 cases (16.6%) tumour metastases to the lymph nodes were found. In total, 10 metastatic lymph nodes were detected in 9 sentinel-nodes and in 1 non-sentinel node. In three patients the nodal metastases were found only in the sentinel nodes. In one patient the metastases were found in the contralateral groin in two SLNs. There were no false nega-tive sentinel lymph nodes. With the sole use of blue dye, SLNs were found in 79.5% of groins. The additional administration of the radiocolloid improved SLN detection to 88.9% of groins.
CONCLUSIONS: The parallel use of the 99mTc labelled radiocolloid and blue dye enables high sentinel node detection rates by adequately trained surgeons.
Nuclear Med Rev 2010; 13, 2: 81–83

Abstract

BACKGROUND: The sentinel lymph node (SLN) biopsy is a solution for decreasing the extent of surgery with a significant reduction of the incidence of complications without influencing treatment results.
MATERIAL AND METHODS: We performed the sentinel lymph node procedure in 24 women with vulvar cancer. In 14 cases, only the blue dye technique was applied, and in 10 cases 99mTc-labelled nanocolloid with blue dye was administered simultaneously. The extent of the surgery included radical vulvectomy in 23 patients and a wide local excision in 1 patient. In 15 patients unilateral inguinofemoral lymphadenectomy was performed and in 9 cases bilateral lymphadenectomy. The total number of operated groins was 39.
RESULTS: SLNs were detected in 34/39 of operated groins (87.2%). In 4 cases (16.6%) tumour metastases to the lymph nodes were found. In total, 10 metastatic lymph nodes were detected in 9 sentinel-nodes and in 1 non-sentinel node. In three patients the nodal metastases were found only in the sentinel nodes. In one patient the metastases were found in the contralateral groin in two SLNs. There were no false nega-tive sentinel lymph nodes. With the sole use of blue dye, SLNs were found in 79.5% of groins. The additional administration of the radiocolloid improved SLN detection to 88.9% of groins.
CONCLUSIONS: The parallel use of the 99mTc labelled radiocolloid and blue dye enables high sentinel node detection rates by adequately trained surgeons.
Nuclear Med Rev 2010; 13, 2: 81–83
Get Citation

Keywords

sentinel lymph node; vulvar cancer; lymphoscintigraphy

About this article
Title

The usefulness of sentinel lymph node detection in vulvar cancer — a short communication

Journal

Nuclear Medicine Review

Issue

Vol 13, No 2 (2010)

Article type

Brief communication

Pages

81-83

Published online

2011-05-20

Bibliographic record

Nucl. Med. Rev 2010;13(2):81-83.

Keywords

sentinel lymph node
vulvar cancer
lymphoscintigraphy

Authors

Sambor Sawicki
Grzegorz Romanowicz
Dariusz Wydra
Piotr Lass

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl